Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Erythropoiesis-stimulating agent resistance and mortality in hemodialysis and peritoneal dialysis patients
Authors
Keywords
Cohort study, Erythropoietin, ESA Resistance, Hemodialysis, Mortality, Peritoneal dialysis
Journal
BMC Nephrology
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-09-26
DOI
10.1186/1471-2369-14-200
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mortality Associated with Dose Response of Erythropoiesis-Stimulating Agents in Hemodialysis versus Peritoneal Dialysis Patients
- (2012) Uyen Duong et al. AMERICAN JOURNAL OF NEPHROLOGY
- Erythropoietin: The swinging pendulum
- (2012) Howard S. Oster et al. LEUKEMIA RESEARCH
- Erythropoiesis-Stimulating Agent Responsiveness and Mortality in Hemodialysis Patients: Results from a Cohort Study From the Dialysis Registry in Japan
- (2011) Shingo Fukuma et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Association of Mean Weekly Epoetin Alfa Dose with Mortality Risk in a Retrospective Cohort Study of Medicare Hemodialysis Patients
- (2011) Eric D. Weinhandl et al. AMERICAN JOURNAL OF NEPHROLOGY
- Addition of Darbepoetin Alfa to Dose-Dense Chemotherapy: Results From a Randomized Phase II Trial in Small-Cell Lung Cancer Patients Receiving Carboplatin Plus Etoposide
- (2011) Sylke Nagel et al. Clinical Lung Cancer
- Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study
- (2011) V. Panichi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Chapter 9: Haemoglobin, Ferritin and Erythropoietin amongst UK Adult Dialysis Patients in 2009: National and Centre-Specific Analyses
- (2011) Julie Gilg et al. NEPHRON CLINICAL PRACTICE
- Iron, Inflammation, Dialysis Adequacy, Nutritional Status, and Hyperparathyroidism Modify Erythropoietic Response
- (2010) A. E. Gaweda et al. Clinical Journal of the American Society of Nephrology
- What is causing the mortality in treating the anemia of chronic kidney disease: erythropoietin dose or hemoglobin level?
- (2010) Ajay K Singh CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- International trends in erythropoietin use and hemoglobin levels in hemodialysis patients
- (2010) Philip A. McFarlane et al. KIDNEY INTERNATIONAL
- Association of ESA hypo-responsiveness and haemoglobin variability with mortality in haemodialysis patients
- (2010) Alexander Kainz et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes
- (2010) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
- (2009) Kamyar Kalantar-Zadeh et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Estimated Effect of Epoetin Dosage on Survival among Elderly Hemodialysis Patients in the United States
- (2009) Y. Zhang et al. Clinical Journal of the American Society of Nephrology
- Relationship between Epoetin Alfa Dose and Mortality: Findings from a Marginal Structural Model
- (2009) O. Wang et al. Clinical Journal of the American Society of Nephrology
- A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
- (2009) Marc A. Pfeffer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL
- (2009) Brian D. Bradbury et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Greater Epoetin alfa Responsiveness Is Associated With Improved Survival in Hemodialysis Patients
- (2008) R. D. Kilpatrick et al. Clinical Journal of the American Society of Nephrology
- Factors that condition the response to erythropoietin in patients on hemodialysis and their relation to mortality
- (2008) Juan M. López-Gómez et al. KIDNEY INTERNATIONAL
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
- (2008) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
- Hemoglobin Control, ESA Resistance, and Regular Low-Dose IV Iron Therapy: A Review of the Evidence
- (2008) Ajay Singh SEMINARS IN DIALYSIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search